{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:14:03Z","timestamp":1792088043852,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.clgc.2022.06.013","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T22:14:30Z","timestamp":1655504070000},"page":"482-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinicopathological Features of FGFR3 - Mutated Upper Tract Urothelial Carcinoma: A Genomic Database Analysis"],"prefix":"10.1016","volume":"20","author":[{"given":"Alessandro","family":"Rizzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Mollica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7340-6173","authenticated-orcid":false,"given":"Matteo","family":"Santoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Massari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2022.06.013_bib0001","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update","volume":"73","author":"Roupr\u00eat","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2022.06.013_bib0002","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update","volume":"79","author":"Roupr\u00eat","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2022.06.013_bib0003","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/14737140.2018.1481395","article-title":"Therapeutic strategies for upper tract urothelial carcinoma","volume":"18","author":"Freifeld","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.clgc.2022.06.013_bib0004","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00345-016-1928-x","article-title":"Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)","volume":"35","author":"Soria","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2022.06.013_bib0005","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.juro.2017.10.019","article-title":"Biological behavior and long-term outcomes of carcinoma in situ in upper urinary tract managed by radical nephroureterectomy","volume":"199","author":"Inamoto","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2022.06.013_bib0006","first-page":"607","article-title":"Trends of incidence and prognosis of upper tract urothelial carcinoma","volume":"21","author":"Wu","year":"2021","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1016\/j.clgc.2022.06.013_bib0007","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.clgc.2020.11.004","article-title":"Upper urinary tract tumors: variant histology versus urothelial carcinoma","volume":"19","author":"Deuker","year":"2021","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2022.06.013_bib0008","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.ejso.2018.12.004","article-title":"Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma","volume":"45","author":"Nazzani","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clgc.2022.06.013_bib0009","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.clgc.2022.06.013_bib0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MOU.0000000000000341","article-title":"Genomics in upper tract urothelial carcinoma","volume":"27","author":"Kammerer-Jacquet","year":"2017","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.clgc.2022.06.013_bib0011","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.euf.2020.08.001","article-title":"Comprehensive genomic profiling of upper-tract and bladder urothelial carcinoma","volume":"7","author":"Necchi","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.clgc.2022.06.013_bib0012","doi-asserted-by":"crossref","first-page":"e1395","DOI":"10.1002\/onco.13839","article-title":"Comparison of genomic characterization in upper tract urothelial carcinoma and urothelial carcinoma of the bladder","volume":"26","author":"Yang","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.clgc.2022.06.013_bib0013","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1078-0432.CCR-18-2039","article-title":"Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma","volume":"25","author":"Audenet","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2022.06.013_bib0014","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1038\/s41467-020-15885-7","article-title":"Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.clgc.2022.06.013_bib0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13059-020-02230-w","article-title":"Comprehensive integrative profiling of upper tract urothelial carcinomas","volume":"22","author":"Su","year":"2021","journal-title":"Genome Biol"},{"key":"10.1016\/j.clgc.2022.06.013_bib0016","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1038\/s41467-019-10873-y","article-title":"Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling","volume":"10","author":"Robinson","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.clgc.2022.06.013_bib0017","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.eururo.2015.07.039","article-title":"Genomic characterization of upper tract urothelial carcinoma","volume":"68","author":"Sfakianos","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2022.06.013_bib0018","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.juro.2016.01.006","article-title":"Genomic biomarkers for the prediction of stage and prognosis of upper tract urothelial carcinoma","volume":"195","author":"Bagrodia","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2022.06.013_bib0019","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.eururo.2017.05.048","article-title":"Comprehensive genomic characterization of upper tract urothelial carcinoma","volume":"72","author":"Moss","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2022.06.013_bib0020","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1097\/CAD.0000000000001200","article-title":"Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data","volume":"33","author":"Ricci","year":"2022","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.clgc.2022.06.013_bib0021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11523-019-00619-7","article-title":"The challenge of managing bladder cancer and upper tract urothelial carcinoma: a review with treatment recommendations from the spanish oncology genitourinary group (SOGUG)","volume":"14","author":"Font","year":"2019","journal-title":"Target Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767322001380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767322001380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:36:06Z","timestamp":1761564966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767322001380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1558767322001380"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2022.06.013","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological Features of FGFR3 - Mutated Upper Tract Urothelial Carcinoma: A Genomic Database Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2022.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}